Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil and growth hormone/IGF-1 secretion in healthy older adults
2005-001315-22Phase 2Completed
- Sponsor
- Ludwig Boltzmann Gesellschaft
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of donepezil in growth hormone deficiency (GHD), sponsored by Ludwig Boltzmann Gesellschaft. Primary endpoints: IGF-1 serum levels and Growth hormone secretion. Started Jan 2006; status: completed.
02
Drugs
donepezil
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on 2005-001315-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001315-22.